We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Haichang Biotech Stock

Invest in or calculate the value of your shares in Haichang Biotech or other pre-IPO companies through EquityZen's platform.

Get Started
View More Companies

Haichang Biotech Stock

Haichang Biotech is a biotech company focusing on the R&D of biopharmaceutical technology.

Invest NowSell Shares

About Haichang Biotech Stock

Founded

2013

Industries

Software, Artificial Intelligence, Data and Analytics

Zhejiang Haichang Biomedical Technology Co., Ltd. is a biotechnology company that focuses on the research and development of biopharmaceutical technology. The company has the ability to innovate independently and holds global intellectual property rights. It is recognized as a national high-tech enterprise. The company's work revolves around the development of innovative biopharmaceutical technologies. It relies on three major technology platforms: nucleic acid delivery technology, lipid nano technology, and microsphere technology, to develop drugs in the fields of vaccines, anti-tumor, analgesia, and anti-infection.

Haichang Biotech Management

Leadership team at Haichang Biotech

President and Founder

Xiaobin Zhao

Locked Features

Join now and verify your accreditation status to gain access to:

  • Haichang Biotech Current Valuation
  • Haichang Biotech Stock Price
  • Haichang Biotech Management
  • Available deals in Haichang Biotech and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Haichang Biotech Cap Table and Funding History by Share Class and Liquidity Preferences
    • Haichang Biotech Revenue and Financials
    • Haichang Biotech Highlights
    • Haichang Biotech Business Model
    • Haichang Biotech Risk Factors
  • Haichang Biotech Research Report from SACRA Research
Join Now

Trading Haichang Biotech Stock

How to invest in Haichang Biotech stock?

Accredited investors can buy pre-IPO stock in companies like Haichang Biotech through EquityZen funds. These investments are made available by existing Haichang Biotech shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.

How to sell Haichang Biotech stock?

Shareholders can sell their Haichang Biotech stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Haichang Biotech